MLAB

Mesa Laboratories, Inc.

$136.91

7.11%
SectorTechnologyIndustryScientific & Technical InstrumentsCountryUnited States

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions.

Source: Yahoo Finance
AI summary

Price & performance

1M+7.4%
3M+34.9%
YTD+73.1%
1Y+68.4%
52-week range—
Beta1.53
Full chart and returns against a benchmark

Q-Score

49/ 100

Quality against peers; 50 is the peer median.

Growth47
Risk53
Performance52
Valuation49
Profitability55
Leverage42
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$249.1M+3.4%
Net income$6.7M
Net margin2.7%+3.5 pts
Historical fundamentals

Red flags in filings

1active red flag
Auditor changeJun 6, 2025
Filings, findings and the timeline

Revenue exposure

53%of revenue from outside the US
United States47%
Other45%
China8%
Regions, segments, customers and suppliers

Valuation

MLABIndustryP/E114.9531.92P/S3.054.83EV/EBITDA25.9322.35P/B3.943.93PEG—0.55
Dividend yield0.46%
Every valuation metric

Earnings

Feb 3next report, after the close
EPS estimate$2.24
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate